SCHEMBL2874377

SCHEMBL2874377

CCCCOc1ccccc1-c1nc(C(=O)O)co1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
CYP19A1 P11511 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
FABP3 P05413 1/20 0.46
FABP4 P15090 1/20 0.46
KDM4E B2RXH2 2/20 0.44
PTPN11 Q06124 2/20 0.44
ENPP1 P22413 2/20 0.44
ENPP3 O14638 1/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.43
CNR2 P34972 4/20 0.42
ALDH1A1 P00352 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PTGER1 P34995 1/20 0.41
POLB P06746 1/20 0.41
TSHR P16473 1/20 0.41
PDE5A O76074 1/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27816822 0.81 IKBKB (0.49) KDM4EALDH1A1SMN1; SMN2TSHR
SCHEMBL9915503 0.77 TP53 (0.39) CYP1A2KDM4EPTPN11ALDH1A1SMN1; SMN2
SCHEMBL17040094 0.76 HDAC1 (0.46) KDM4EPTPN11CNR2ALDH1A1SMN1; SMN2
SCHEMBL92482 0.76 CNR2 (0.64) CYP1A2CYP19A1CYP2C9CYP2C19KDM4E
SCHEMBL10750541 0.76 PTPN11 (0.64) CYP1A2CYP19A1CYP2C9CYP2C19KDM4E
SCHEMBL15190365 0.75 SCN9A (0.46) CYP2C9KDM4EALDH1A1POLB
SCHEMBL16748705 0.74 TP53 (0.37) KDM4EPTPN11CNR2ALDH1A1SMN1; SMN2
SCHEMBL17931473 0.74 TOP2A (0.52) CYP1A2CYP19A1CYP2C9CYP2C19FABP3
SCHEMBL7744187 0.74 HDAC1 (0.49) ENPP1ENPP3ALDH1A1SMN1; SMN2TSHR
SCHEMBL9915358 0.73 S1PR3 (0.37) KDM4EPTPN11ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102137851-B Compound as vanilloid receptor antagonist, isomer thereof or pharmaceutically acceptable salt thereof, and pharmaceutical composition comprising same AMOREPACIFIC CORP 2014-08-27 CN disclosed
EP-2307394-B1 SULPHONAMIDES AS VANILLOID RECEPTOR ANTAGONIST AMOREPACIFIC CORP (KR) 2012-09-26 EP disclosed
CN-102137851-A Novel compounds as vanilloid receptor antagonists, isomers thereof or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the same AMOREPACIFIC CORP 2011-07-27 CN disclosed
WO-2010002209-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2010-01-07 WO disclosed